Literature DB >> 14675082

Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIII.

D A Wilcox1, Q Shi, P Nurden, S L Haberichter, J B Rosenberg, B D Johnson, A T Nurden, G C White, R R Montgomery.   

Abstract

von Willebrand factor (VWF) is a complex plasma glycoprotein that modulates platelet adhesion at the site of a vascular injury, and it also serves as a carrier protein for factor (F)VIII. As megakaryocytes are the only hematopoietic lineage to naturally synthesize and store VWF within alpha-granules, this study was performed to determine if expression of a FVIII transgene in megakaryocytes could lead to trafficking and storage of FVIII with VWF in platelet alpha-granules. Isolex selected CD34+ cells from human G-CSF mobilized peripheral blood cells (PBC) and murine bone marrow were transduced with a retrovirus encoding the B-domain deleted form of human FVIII (BDD-FVIII). Cells were then induced with cytokines to form a population of multiple lineages including megakaryocytes. Chromogenic analysis of culture supernatant from FVIII-transduced human cells demonstrated synthesis of functional FVIII. Treatment of cells with agonists of platelet activation (ADP, epinephrine, and thrombin receptor-activating peptide) resulted in the release of VWF antigen and active FVIII into the supernatant from transduced cells. Immunofluorescence analysis of cultured human and murine megakaryocytes revealed a punctate pattern of staining for FVIII that was consistent with staining for VWF. Electron microscopy of transduced megakaryocytes using immunogold-conjugated antibodies colocalized FVIII and VWF within the alpha-granules. FVIII retained its association with VWF in human platelets isolated from the peripheral blood of NOD/SCID mice at 2-6 weeks post-transplant of transduced human PBC. These results suggest feasibility for the development of a locally inducible secretory pool of FVIII in platelets of patients with hemophilia A.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675082     DOI: 10.1111/j.1538-7836.2003.00534.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  16 in total

1.  Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis.

Authors:  S Kanaji; S A Fahs; Q Shi; S L Haberichter; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

2.  VWF and FVIII: the origins of a great friendship.

Authors:  Sandra L Haberichter
Journal:  Blood       Date:  2009-03-26       Impact factor: 22.113

Review 3.  Platelet and endothelial expression of clotting factors for the treatment of hemophilia.

Authors:  Robert R Montgomery; Qizhen Shi
Journal:  Thromb Res       Date:  2012-03-14       Impact factor: 3.944

4.  C560Rβ3 caused platelet integrin αII b β3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality.

Authors:  J Fang; P Nurden; P North; A T Nurden; L M Du; N Valentin; D A Wilcox
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

5.  Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies.

Authors:  Qizhen Shi; David A Wilcox; Scot A Fahs; Hartmut Weiler; Clive W Wells; Brian C Cooley; Drashti Desai; Patricia A Morateck; Jack Gorski; Robert R Montgomery
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 6.  Megakaryocyte- and megakaryocyte precursor-related gene therapies.

Authors:  David A Wilcox
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

7.  Correction of murine Bernard-Soulier syndrome by lentivirus-mediated gene therapy.

Authors:  Sachiko Kanaji; Erin L Kuether; Scot A Fahs; Jocelyn A Schroeder; Jerry Ware; Robert R Montgomery; Qizhen Shi
Journal:  Mol Ther       Date:  2011-11-01       Impact factor: 11.454

8.  Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.

Authors:  Juan Fang; Kairbaan Hodivala-Dilke; Bryon D Johnson; Lily M Du; Richard O Hynes; Gilbert C White; David A Wilcox
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

Review 9.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

10.  Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells.

Authors:  Maartje van den Biggelaar; Eveline A M Bouwens; Neeltje A Kootstra; Robert P Hebbel; Jan Voorberg; Koen Mertens
Journal:  Haematologica       Date:  2009-03-31       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.